- Home
- MURA vs CUE Comparison
MURA vs CUE Comparison
Compare MURA & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MURA
- CUE
- Stock Information
- Founded
- MURA 2013
- CUE 2014
- Country
- MURA Ireland
- CUE United States
- Employees
- MURA N/A
- CUE N/A
- Industry
- MURA
- CUE Biotechnology: Pharmaceutical Preparations
- Sector
- MURA
- CUE Health Care
- Exchange
- MURA Nasdaq
- CUE Nasdaq
- Market Cap
- MURA N/A
- CUE 60.6M
- IPO Year
- MURA N/A
- CUE 2018
- Fundamental
- Price
- MURA $1.26
- CUE $0.90
- Analyst Decision
- MURA Strong Buy
- CUE Strong Buy
- Analyst Count
- MURA 5
- CUE 4
- Target Price
- MURA $13.00
- CUE $4.75
- AVG Volume (30 Days)
- MURA 419.4K
- CUE 154.3K
- Earning Date
- MURA 03-11-2025
- CUE 05-08-2025
- Dividend Yield
- MURA N/A
- CUE N/A
- EPS Growth
- MURA N/A
- CUE N/A
- EPS
- MURA N/A
- CUE N/A
- Revenue
- MURA N/A
- CUE $9,532,000.00
- Revenue This Year
- MURA $79.64
- CUE $73.11
- Revenue Next Year
- MURA N/A
- CUE $11.02
- P/E Ratio
- MURA N/A
- CUE N/A
- Revenue Growth
- MURA N/A
- CUE 149.53
- 52 Week Low
- MURA $1.12
- CUE $0.45
- 52 Week High
- MURA $5.02
- CUE $2.26
- Technical
- Relative Strength Index (RSI)
- MURA 19.38
- CUE 31.10
- Support Level
- MURA $3.77
- CUE $0.95
- Resistance Level
- MURA $4.35
- CUE $1.05
- Average True Range (ATR)
- MURA 0.26
- CUE 0.08
- MACD
- MURA -0.30
- CUE 0.00
- Stochastic Oscillator
- MURA 4.92
- CUE 11.54
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.